ABBV

ABBVIE INC.
Data: 2026-07-13
$248
Price
-0.03%
Change
$261.64
52W High
$184.63
52W Low

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Quick Stats
Jul 13, 2026

58.9

AI Score

HOLD

0.52

Volume Ratio

Jul 31, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

ABBV Stock Summary

Last updated Jul 13, 2026

ABBV is currently trading at $248, positioned above its 200-day moving average of $222.9, indicating a long-term uptrend. The stock has a 52-week range of $184.63 to $261.635.

Technical Analysis: The 50-day moving average stands at $224.8, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 60.317, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.359, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ABBV at 58.9/100 with a HOLD recommendation.

ABBV (ABBVIE INC.) Indicators

Last updated Jul 13, 2026

Indicator Value
RSI(14) 60.317
CMF (20) 0.359
ROC (10) -2.112
ADX (14) 33.243
Indicator Value
MACD (12,26,9) 8.297
AROONOSC (14) 57.143
WILLAMS %R (14) -44.948
MFI (14) 64.93
ABBV Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABBV Price vs Max Options Open Interest
ABBV Max Change In Options Open Interest

ABBV Options - Sort by Max open Interest (near term)

13th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Daily Out of Money Options - Sort by Max open Interest (near term)

13th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Daily In the Money Options - Sort by Max open Interest (near term)

13th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABBV Most Active Options by Volume(near term)

13th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

ABBVIE INC. is above both 50 Day and 200 Day SMA which is considered Bullish.

ABBV Moving Averages Analysis

ABBVIE INC. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 13, 2026

ABBVIE INC. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 13, 2026

ABBV (ABBVIE INC.) Simple Moving Averages

Moving Averages are last updated Jul 13, 2026

Days MA
10 252.62
20 241.59
30 234.85
50 224.8
100 220.02
200 222.9

ABBV Fundamental Analysis

P/E (Forward) 17.4216
P/E (Trailing) 122.2069
Market Cap ($) 438.3 billion
Earnings/Share ($) 2.03
Net Proft Margin (%) 0.0579
Dividend/Share ($) 6.74
EPS Estimate Current Year ($) 14.1999
EPS Estimate Next Year ($) 16.2862
WallStreet Target Price ($) 262.9286
Most Recent Quarter